|

BIOmarkers in Patients With Pancreatic Cancer ("BIOPAC")

RECRUITINGSponsored by Inna Chen, MD
Actively Recruiting
SponsorInna Chen, MD
Started2008-07-03
Est. completion2035-07-02
Eligibility
Age19 Years+
View on ClinicalTrials.gov →

NCT03311776

Summary

No validated biomarkers to identify PC at an early stage and to predict treatment outcomes in the individual patient exist. The objective of the present study is to find diagnostic, prognostic and predictive biomarkers.

Eligibility

Age: 19 Years+
Inclusion Criteria:

* Age \> 18 years
* Histologically verified PC (ductal adenocarcinoma) or ampullary adenocarcinoma in a resected specimen; or histopathological confirmation of carcinoma in patients not undergoing surgery in the setting of clinical and radiological characteristics which, together with the pathology, are consistent with a diagnosis of PC independently of stage

Exclusion Criteria:

• None

Conditions2

CancerPancreatic Cancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.